Here are relevant reports on : diagnostic-disinfectant-market
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Mammography Detector Market by type (analog and digital detectors) by technology (DC and IC detectors) by end-user (hospitals, diagnostic imaging centers, and others) and by Region - Global Forecast to 2030
The major players in the global Mammography Detector Market
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Clot Management Market by Product [Percutaneous Thrombectomy (Mechanical, Aspiration), Embolectomy Balloon, CDT, Inferior Vena Cava Filter (Permanent, Retrievable), & Neurovascular Embolectomy] & End User (Hospital, Diagnostic) - Global Forecasts to 2019
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Ophthalmic Equipment Market by Technology (AI-enabled Equipment), Product Type (Surgical Devices (Ophthalmic Microscopes), Diagnostic & Monitoring Devices (Optical Coherence Tomography Scanners, Slit Lamps) ), End User (Hospitals) - Global Forecast to 2030
The global ophthalmic equipment market, valued at US$18.61 billion in 2024, stood at US$19.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$26.14 billion by the end of the period.
- Published: November 2025
- Price: $ 7150
- TOC Available:
-
Dental Digital X-ray Market by Product (Digital, Analog), Type (Intraoral (Panoramic), Extraoral (Digital Sensor), Hybrid), Application (Diagnostic, Therapeutic), End User (Dental Hospitals, Forensic Laboratories), & Region - Global Forecasts to 2027
The global dental digital x-ray market, stood at US$4.0 billion in 2022 and is projected to advance at a resilient CAGR of 11.9% from 2023 to 2028, culminating in a forecasted valuation of US$7.0 billion by the end of the period. This growth is driven by technological advancements that improve image quality and reduce diagnostic time, and the increasing use of CBCT in dentistry. The rise in medical tourism, particularly in emerging economies, offers significant growth opportunities.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
The global clinical informatics market, valued at US$198.33 billion in 2023, stood at US$231.45 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2030, culminating in a forecasted valuation of US$563.18 billion by the end of the period. Technological advancements in clinical informatics solutions, the rising need for improved data standardization, and the growing adoption of integrated solutions in clinical applications are key factors driving the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
The global albumin & creatinine tests market growth is primed to transition from $987 million in 2020 to $2,103 million by 2025, showcasing a strong CAGR of 16.3%. The growth of this market is driven by the growing prevalence of kidney disorders and diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030
The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
